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ABSTRACT 
Introduction 
Nausea and vomiting are common symptoms for patients with advanced cancer. While 
there is evidence for acupuncture point stimulation for treatment of these symptoms for 
patients having anti-cancer treatment there is little for when they are not related to such 
treatment. 
 
Objective 
To determine whether acupressure at the Pericardium 6 site can help in the treatment of 
nausea and vomiting suffered by palliative care patients with advanced cancer.  
 
Materials and methods 
Double blind randomised controlled trial – active versus placebo acupressure 
wristbands. 
In-patients with advanced cancer in two specialist palliative care units who fitted either or 
both of the following criteria were approached: 
Nausea that was at least moderate 
Vomiting daily on average for the prior three days 
 
Results 
57 patients were randomised to have either active or placebo acupressure wristbands. 
There was no difference in any of the outcome measures between the 2 groups: 
• Change from baseline number of vomits 
• Visual Analogue Scale for ‘did acupressure wristbands help you to feel better?’ 
• Total number of as needed doses of anti-emetic medication 
• Need for escalation of anti-emetics 
 
 
Conclusions: 
In contrast to a previously published feasibility study, active acupressure wristbands 
were no better than placebo for specialist palliative care in-patients with advanced 
cancer and nausea and vomiting. 
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INTRODUCTION 
Nausea and vomiting are problems for up to 70% of patients with advanced cancer1. 
Management of these patients rests on trying to treat any underlying cause. If this is not 
possible, and whilst the underlying cause is being treated, anti-emetics are used. Careful 
patient assessment allows clinicians to choose an appropriate first-line anti-emetic2 
based on what is thought to be the underlying neuropharmacological mechanism.   
While this is a widespread approach there is little evidence for the drugs commonly used 
for these symptoms in this patient group3,4. A recent study has challenged whether this 
mechanistic approach is correct and whether symptom control could be just as good 
using one drug5. 
Acupuncture originated in China over 2000 years ago and is now used globally. It is a 
technique where needles are inserted in predetermined areas (or acupuncture points) in 
the body. For nausea, while many acupuncture points have been described for 
prevention or treatment of nausea, the most commonly described is P6 (Pericardium 6)6. 
This point is located 2 cun (a Chinese measurement equal to approximately 3cm) 
proximal to the midpoint of the transverse crease of the wrist between the tendons of 
palmaris longus and flexor carpi radialis. There is mixed evidence for acupuncture point 
stimulation for control of nausea in pregnancy7 and post-operative nausea8. For patients 
with cancer, the majority of studies relate to chemotherapy9,10 or radiotherapy11,12. 
Acupressure is an attractive alternative to acupuncture involving pressure on 
acupuncture points13. There is methodological heterogeneity for randomised controlled 
trials of acupressure and when sham acupressure is used there are a number of 
alternatives for the sham intervention including acupressure at non-acupuncture points 
or sham acupressure at real points14. 
In a large study of patients with chemotherapy-induced nausea, patients were 
randomised to active wristbands, sham wristbands, or no wristband. Patients in all 
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groups received anti-emetics. Both sets of wristbands were elasticated with a small stud 
which could apply pressure to an acupuncture point. In the active group, this would be 
placed at P6, in the sham group the bands were placed so that the stud faced outward, 
not putting pressure on P6. In this large study 500 patients were randomised. There 
were no statistical differences between the outcomes for the groups although slightly 
less nausea in the active and sham groups combined when compared with no band15, 
and slightly lower healthcare costs for those who had bands16. 
We wished to see whether acupressure wristbands placed at the P6 site can help 
patients with terminal cancer who are suffering from nausea and vomiting. There are a 
number of reasons why acupressure would be a useful choice for such patients if it 
helped their symptoms. Firstly, it is relatively easy to apply. Patients (or their carers if 
they were too fatigued) can place the bands after receiving simple instruction allowing 
them some control over treatment. Secondly, this can be done at home without the need 
for a trip to the hospital or hospice for medication. Thirdly, this technique can be used 
safely in patients with clotting disorders, thrombocytopenia and neutropenia when 
acupuncture would be contraindicated. Fourthly, it is a technique which is extremely well 
tolerated. Very few patients have side-effects from wearing the bands and those who do 
complained only of sensations of tightness, swollen hands and itchy wrists17 although 
blistering at the site of the stud has been reported18. We know of no reports of serious 
adverse effects of acupressure in patients. 
There have been very few investigations of acupressure wristbands for cancer patients 
where the cause of the nausea has not been chemotherapy or radiotherapy19,20 and only 
one randomised trial21. In this small feasibility study 10 patients were randomised to 
active or placebo acupressure wristbands. That study allowed power calculations to 
inform the study presented here. As in the feasibility study, patients were allowed anti-
emetics alongside the acupressure intervention. 
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PATIENTS, MATERIALS AND METHODS 
Between 17.06.10 and 01.01.18 adult in-patients at two Specialist Palliative Care Units 
were approached if they met the following inclusion criteria: 
1. Diagnosis of advanced cancer with an estimated prognosis of less than 1 year 
but more than 3 days. 
2. Nausea as at least moderate on a none/mild/moderate/severe scale OR had at 
least one vomit per day for the last three days. 
3. Have an underlying cause for their nausea thought to be irreversible OR the 
patient has made an autonomous choice not to proceed with treatment for any 
potentially reversible cause (for example surgery for bowel obstruction or 
drainage of ascites). 
4. If patients are taking corticosteroids the dosage should be stable for 3 days 
before and during the trial. 
 
Exclusion criteria 
1. Arm lymphoedema. 
2. Weakness, fatigue or confusion sufficient that patient is unable to take part. 
3. Previous history of acupuncture/acupressure for nausea or vomiting, or history of 
use of acupressure by a close relative. 
4. History of Parkinsonism or Parkinsonism on examination (as metoclopramide 
included in treatment escalation schedule for patients with suspected gastric 
stasis) 
5. Sharing a room with another patient taking part in the study. 
6. Unable to read or comprehend the questionnaires or Visual Analogue Scale 
(VAS). 
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If patients were positive about participation the study was described to them by a 
member of the research team and a patient information leaflet given to them. They were 
given a minimum of 1 hour to consider participation. If after this time they were happy to 
proceed they were asked to sign a consent form. 
A baseline assessment was then completed by a member of the research team 
documenting the likely clinical picture or cause for nausea. The patient was asked to 
complete a baseline VAS nausea rating. 
Pairs of active or placebo acupressure wristbands had previously been placed in 
sequential numbered envelopes according to a sequence derived from 
randomization.com. The bands were provided free of charge by Sea-Band Ltd. They 
appeared the same when in place, the difference being that active bands have a 
spherical bead exerting pressure while sham bands have no such bead.  
The bands were placed on participants’ wrists at the correct P6 points by a member of 
the research team not involved with clinical decision making for the patient. 
Patients’ anti-emetics were not altered on Day 0 and they continued their current anti-
emetic regimen which could be as needed, regular oral or subcutaneous medication, or 
a constant infusion via subcutaneous syringe driver. 
For the next 3 days the patient was assessed by a clinician (blinded to the type of 
acupressure bands in place) and asked if the patient felt that their nausea / vomiting 
control was good enough. If not, the clinician could escalate the patient’s anti-emetics 
according to a pre-defined treatment escalation schedule. This schedule took account of 
the most likely clinical picture. If regular oral anti-emetics did not give adequate symptom 
control patients were offered a constant infusion via a subcutaneous syringe driver.  
In-patient unit nursing staff reminded patients to complete their daily nausea 
assessments and estimate of efficacy. Patient participation in the study finished on Day 
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3. Wristbands were then removed, and patients had the option of wearing a normal pair 
of acupressure wristbands if they wished. 
 
Outcome Measures: 
Primary outcome measures were determined by the feasibility study: 
• Change from baseline number of vomits 
• VAS for ‘did acupressure wristbands help you to feel better?’ 
• Total number of as needed doses of anti-emetic medication 
• Need for escalation of anti-emetics 
Secondary outcome measures were: 
• VAS of nausea measured daily.  
• Duration of perceived nausea over previous 24 hours. 
• Adverse effects of acupressure. 
 
Statistical Analysis 
Descriptive statistics were used to characterise the cohort. The frequency with 
percentages are reported for categorical outcome measures and median with 
interquartile range values are reported for the continuous variable outcome measures. 
The non-parametric Mann-Whitney U and Fisher’s test were used to compare outcomes. 
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RESULTS 
57 patients were recruited to the study (30 in the active arm and 27 in the placebo arm). 
Two patients in the active arm became too unwell before they could contribute any data 
so they have not been included in analysis. For CONSORT Diagram see Figure 1 and 
baseline characteristics see Table 1. Patients in the placebo arm had a higher average 
baseline nausea VAS but this was not of statistical significance. There was no difference 
between the numbers of patients receiving oral medication or via a syringe driver but 
there were more patients in the active arm receiving injections of anti-emetics. 
Table 1. Baseline characteristics  
 Active 
(n = 28) 
Placebo 
(n = 27) 
p-value 
Age, years; median (IQR) 65.5 (57.5 – 75.0) 67.0 (59.0 – 71.0) 0.743 
Females 24 (85.7) 24 (88.9) 0.724 
Diagnosis    
 
 
 
0.615 
Upper Gastrointestinal Tract 4 6 
Lower Gastrointestinal Tract 3 4 
Pancreas / gall bladder 6 4 
Lung 6 4 
Ovary 3 5 
Breast 2 2 
Other 4 2 
Nausea level    
 
0.970 
 
None 4 (14.3) 5 (18.5) 
Mild 7 (25.0) 7 (25.9) 
Moderate 14 (50.0) 12 (44.4) 
Severe 3 (10.7) 3 (11.1) 
Baseline Nausea VAS, median (IQR) 28.5 (12.5 – 56.5) 38.5 (13.0 – 58.0) 0.580 
Pattern of nausea  None-mild 8 (28.6) 6 (22.2) 0.589 
0.221 
0.912 
0.646 
0.092 
0.358 
And associated         Sudden onset 
symptoms           
20 (71.4) 15 (55.6) 
                              Movement-related 11 (36.3) 11 (40.7) 
                              Obstructive 11 (36.3) 9 (33.3) 
                              Medication cause 5 (17.9) 1 (3.7) 
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                              Constipation 12 (42.9) 8 (30.8) 
   
Regular Antiemetic at baseline None 2 0 
Cyclizine 6  7 
Metoclopramide 17  14 
Haloperidol 13  18 
Levomepromazine 23  19 
Ondansetron 3  0 
Route of anti-emetic administration    
PO 25 20 0.551 
SC injection 38 17 0.001 
CSCI 16 23 0.098 
Regularity    
 
 
0.433 
PRN only 2 0 
OD 2  4 
TDS 8 4 
CSCI 16 23 
BD 0 1 
 
 
Results for primary and secondary outcome measures are in Table 2 and 3 respectively. 
For each of days 1 – 3 there was no difference between the groups with regard to any of 
the outcome measures. 
The main adverse event was that the bands felt too tight and this led to one patient in 
each arm withdrawing from the study before day 3. Levels of missing data varied from 
4.4 to 15.1% for different outcome measures.  
Table 2 – Primary Outcome Measures 
Results for interventions 
 Active 
(n = 28) 
Placebo 
(n = 27) 
p-value 
Total number of study days 84 75 0.940 
Day 1 28 27  
Day 2 28 24  
Day 3 28 24  
Average number of vomits at baseline 
(previous 3 days), median (IQR) 
2 (1 – 3) 2 (1 – 3) 0.9112 
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Average number of vomits during 3-day study 
period, median (IQR) 
1.2 (0.5 – 1.8) 0.7 (0.3 – 2.0) 0.5657 
Number with missing data on vomits 4 3  
Difference in average number of vomits 
-0.7 (-1.7 – 0) -0.8 (-1.5 – -0.3) 0.9288 
Do you think the acupressure wristbands 
helped you to feel better? mm, median (IQR) 
 
35 (11 – 63) 
 
46.5 (8 – 80.5) 
 
0.7528 
Day 1 47 (18.5 – 73) 30 (4 – 82) 0.4181 
No. with missing value 4 2  
Day 2 32 (6 – 54) 53 (14 – 87) 0.2199 
No. with missing value 1 8  
Day 3 43 (10 – 66.5) 52 (14 – 62.5) 0.9861 
No. with missing value 4 7  
Total number of PRN doses 65 50 0.1317 
Escalation of antiemetic    
 
0.957 
No 70 60 
Yes 14 13 
Number with missing value 0 2 
 
 
Table 3  Secondary Outcome Measures 
Results for interventions 
 
 Active 
(n = 28) 
Placebo 
(n = 27) 
p-value 
Nausea VAS mm (all 3 days), median 
(IQR) 
22.5 (6.5 – 58) 21 (7 – 43) 0.5736 
Baseline (Day 0) 28.5 (12.5 – 56.5) 38.5 (13.0 – 58.0) 0.580 
Day 1 23.5 (8 – 50.5) 28 (6 – 55) 0.9035 
No. with missing VAS 4 4  
Day 2 24.5 (8 – 55) 17 (3 – 37) 0.21146 
No. with missing VAS 2 7  
                                  Day 3 18 (2 – 71) 26 (7 – 42) 0.9387 
No. with missing VAS 2 5  
Time nauseated over last 24 hours 
(all 3 days) 
  0.769 
< ¼  42 31  
¼ - ½  15 17  
½ - ¾  11 10  
¾ - 1 8 8  
No. with missing value 8 9  
11 
Adverse Event 15 13 0.299 
Side effect type   0.166 
Dug in 1 0  
Giddy 1 0  
Itchy 3 0  
Tired 1 0  
Too tight 9 13  
 
 
 
CONCLUSIONS 
This is the first adequately powered randomised controlled trial of active versus placebo 
acupressure wristbands for nausea and vomiting in a terminally ill palliative care 
population where the focus was not chemotherapy or radiotherapy. The study took 
longer to recruit to than hoped. Most patients admitted did not fit the inclusion criteria. 
The most common reasons were because nausea or vomiting was not severe enough; 
or that patients did not fit the prognostic criteria. There were different levels of missing 
data in our study. The reason for missing data was largely when patients became too 
unwell to complete assessments or misinterpreted how to complete VASs, although 
there were instances where nurses did not document the number of vomits per day. 
Missing data is increasingly recognised as a problem in palliative care research22. While 
any missing data is disappointing, levels in this study were lower than those reported in 
a recent systematic review23. It’s likely that this was because of a relatively short study 
over 3 days with outcome measures that are straightforward to complete. 
Adverse events were not severe and only two patients withdrew because of them.  
In a recent systematic review examining the role of acupressure for chemotherapy-
induced nausea and vomiting, acupressure reduced the severity of acute and delayed 
nausea24. However, in their subgroup analyses non-sham-controlled trials tended 
towards significance while the sham-controlled trials did not, suggesting that sham 
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acupressure had a placebo effect. In another study patients were asked whether they 
expected wristbands to work and those that did had more chance of an effect, which the 
authors say may be another pointer to a placebo effect25. This and another study 
showed variable effects of gender on response with one showing better efficacy in men25 
and another in women15. 
In our study, there was no evidence of a sham placebo effect as neither group showed 
an improvement in any of the outcome measures. 
So, where does this leave the use of acupressure wristbands for palliative care patients? 
This study shows that in this hospice in-patient unit population active bands are not 
better than placebo. It is difficult to argue that medication worked well for this population 
as symptoms did not improve greatly in either arm. The number of vomits per day 
decreased in both arms but this did not reach statistical significance. There are some 
interesting questions which remain. It is unclear whether acupressure would have 
worked better for one mechanism of nausea and vomiting rather than another (e.g. 
biochemical nausea rather than gastric stasis). There were not enough patients in each 
group to be able to ascertain this. Perhaps wristbands would have worked better for less 
symptomatic patients, e.g. those seen as out-patients or at home. They do not appear to 
work in this highly symptomatic population. For now, we will advocate the use of 
wristbands only for those palliative care patients who are keen to try an intervention that 
does not involve drugs with the explanation that there is little evidence to support their 
use.  
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